StemMACS™ Cre Recombinase mRNA

StemMACS™ Cre Recombinase mRNA encodes a codon-optimized variant of Cre recombinase for transient transfection.

Related products for StemMACS™ Cre Recombinase mRNA

Specifications for StemMACS™ Cre Recombinase mRNA
Overview

StemMACS™ Cre Recombinase mRNA encodes a codon-optimized variant of Cre recombinase for transient transfection.

Applications
  • site-specific recombination between loxP sites
Detailed product information
Background information

Cre recombinase is a tyrosine recombinase enzyme derived from the P1 bacteriophage that catalyzes site-specific recombination between two DNA recognition sites (loxP sites).

Detailed procedure

For satisfactory transfection results, use a transfection protocol optimized for your specific cell type. StemMACS™ eGFP mRNA or StemMACS™ Nuclear eGFP mRNA allow easy evaluation of transfection efficiency and are recommended as positive controls.

Quality description

StemMACS™ mRNAs are highly pure, in vitro-transcribed mRNAs that have been carefully optimized to ensure high level expression after transfection. Polyadenylation and enzymatic cap mimic a fully processed mature mRNA and ensure efficient translation. Incorporation of the modified nucleotides pseudouridine and 5-methylcytidine reduces the innate antiviral response to single-stranded mRNA. Robust expression of the encoded factor after transfection has been verified by immunofluorescence or flow cytometry.

StemMACS™ mRNAs are lyophilized from a 0.2 µM filtered solution for extended shelf-life.

Product data and images for StemMACS™ Cre Recombinase mRNA
Figure 1

Cre-mediated recombination in mouse ES cells: HM1 embryonic stem cells carrying a GFP reporter gene that is transcribed upon cre-mediated recombination were electroporated with 3 μg StemMACS™ Cre Recombinase mRNA and analyzed by flow cytometry 24 hours after transfection. 72% of all cells were GFP-positive indicating successful cre-mediated recombination.

Figure 2

Full control over recombination efficiency: The optimal amount of StemMACS™ Cre Recombinase mRNA can be determined by titration. In the case of the HM1 reporter line described above, a single electroporation with >3 μg StemMACS™ Cre Recombinase mRNA resulted in 70-80% recombination. Transfection efficiency was >80% as determined by independent electroporation of StemMACS™ eGFP mRNA into control HM1 cells (not shown).

Citations for StemMACS™ Cre Recombinase mRNA
Publications
  1. Bayindir-Buchhalter, I. et al. (2018) Cited4 is a sex‐biased mediator of the antidiabetic glitazone response in adipocyte progenitors. EMBO Mol. Med. 4 (10): e8613
  2. Blanch-Asensio, A. et al. (2022) STRAIGHT-IN enables high-throughput targeting of large DNA payloads in human pluripotent stem cells. Cell Rep Methods. 2 (10): 100300
  3. Turkalo, T.K. et al. (2023) A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells. Nat Commun 14: 939
  4. Celis-Gutierrez, J. et al. (2019) Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep 27 (11): 3315-3330

You have previously chosen International as your location.
What do you want to do?